Skip to main content

Table 2 CDKN2B-AS1 (rs1333049) and ZFHX3 (rs2106261) gene polymorphisms of COVID-19 patients and healthy controls

From: Association between cyclin-dependent kinase inhibitor 2B antisense RNA 1 and zinc finger homeobox 3 gene polymorphisms and COVID-19 severity

 

Severe COVID-19 cases

(n = 90)

Moderate COVID-19 cases

(n = 90)

Healthy controls

(n = 180)

χ2

p

No.

%

No.

%

No.

%

CDKN2B-AS1 (rs1333049)

        

G/G

12

13.3

18

20.0

88

48.9

49.106*

< 0.001*

G/C

64

71.1

48

53.3

68

37.8

 C/C

14

15.6

24

26.7

24

13.3

HWχ2 (p)

16.098(< 0.001*)

0.459(0.498)

3.286(0.070)

  

Allele

        

G

88

48.9

84

46.7

244

67.78

29.696*

< 0.001*

C

92

51.1

96

53.3

116

32.22

ZFHX3 (rs2106261)

        

C/C

56

62.2

66

73.3

128

71.1

5.3884

MCp = 0.253

 C/T

34

37.8

24

26.7

50

27.8

T/T

0

0.0

0

0.0

2

1.1

HWχ2 (p0)

4.881(0.027*)

2.130(0.144)

1.436(0.231)

  

Allele

        

C

146

81.1

156

86.7

306

85.0

2.2838

0.319

T

34

18.9

24

13.3

54

15.0

  1. χ2: Chi square test MC: Monte Carlo
  2. p: p value for comparing COVID-19 patients and healthy controls
  3. *: Statistically significant at p ≤ 0.05
  4. HWχ2 (p0): Chi square for goodness of fit for Hardy-Weinberg equilibrium (If P < 0.05 - not consistent with HWE)